Related references
Note: Only part of the references are listed.Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylation
Feng-Ming Wang et al.
BIOCHEMICAL JOURNAL (2011)
Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma
J. Bae et al.
LEUKEMIA (2011)
XBP1: the last two decades
L. H. Glimcher
ANNALS OF THE RHEUMATIC DISEASES (2010)
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments
Tina Bagratuni et al.
BLOOD (2010)
TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages
Fabio Martinon et al.
NATURE IMMUNOLOGY (2010)
Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation
Yuko Hiruma et al.
BLOOD (2009)
Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro
Liping Wang et al.
BONE (2009)
IRE1α Kinase Activation Modes Control Alternate Endoribonuclease Outputs to Determine Divergent Cell Fates
Dan Han et al.
CELL (2009)
The IRE1α-XBP1 Pathway of the Unfolded Protein Response Is Required for Adipogenesis
Haibo Sha et al.
CELL METABOLISM (2009)
XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells
Chih-Chi Andrew Hu et al.
EMBO JOURNAL (2009)
Intracellular Autoactivation of Human Cationic Trypsinogen Mutants Causes Reduced Trypsinogen Secretion and Acinar Cell Death
Eva Kereszturi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
Unconventional splicing of XBP-1 mRNA in the unfolded protein response
Hiderou Yoshida
ANTIOXIDANTS & REDOX SIGNALING (2007)
The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies
Constantine S. Mitsiades et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-a expression and contributes to angiogenesis and tumor growth in vivo
Benjamin Drogat et al.
CANCER RESEARCH (2007)
Phosphorylation of HuR by Chk2 regulates SIRT1 expression
Kotb Abdelmohsen et al.
MOLECULAR CELL (2007)
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis
Daniel R. Carrasco et al.
CANCER CELL (2007)
Divergent roles of IRE1α and PERK in the unfolded protein response
M Schröder et al.
CURRENT MOLECULAR MEDICINE (2006)
Pathogenesis of myeloma bone disease
GD Roodman
BLOOD CELLS MOLECULES AND DISEASES (2004)
A trip to the ER: coping with stress
DT Rutkowski et al.
TRENDS IN CELL BIOLOGY (2004)
Anti-α4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis
Y Mori et al.
BLOOD (2004)
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells
AH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response
NN Iwakoshi et al.
IMMUNOLOGICAL REVIEWS (2003)
Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1
NN Iwakoshi et al.
NATURE IMMUNOLOGY (2003)
A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference
DA Rubinson et al.
NATURE GENETICS (2003)
Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors
C Lois et al.
SCIENCE (2002)
Plasma cell differentiation requires the transcription factor XBP-1
AM Reimold et al.
NATURE (2001)